Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer.
Conclusions: This study failed to demonstrate that induction TPF chemotherapy improves survival in patients with BOT and hypopharynx cancer. However, it suggested a favorable outcome with IC to this population.
PMID: 32241084 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Lim SH, Sun JM, Hong J, Oh D, Ahn YC, Chung MK, Jeong HS, Son YI, Ahn MJ, Baek CH, Park K Tags: Korean J Intern Med Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Docetaxel | Head and Neck Cancer | Hypopharyngeal Cancer | Internal Medicine | Squamous Cell Carcinoma | Study | Taxotere